… -fold (p < 0.0001) compared with Victoria and 3.6-fold (p < 0.0001… -fold (p < 0.0001) compared
with Victoria and 3.6-fold (p < … 2.7-fold (p < 0.0001) and 34.2fold (p < 0.0001) following the …

The development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines
and therapeutics will depend on understanding viral immunity. We studied T cell memory …

… P.1 is much more compromised. Inspection of the neutralization curves using B.1.351 and
P.… .2, most profoundly for P.1, suggesting that individuals infected with B.1.351 and P.1 may be …

The Omicron lineage of SARS-CoV-2, which was first described in November 2021, spread
rapidly to become globally dominant and has split into a number of sublineages. BA.1 …

… The Wilcoxon matched-pairs signed rank sum test was used for the analysis and two-tailed
p values were calculated; geometric mean values are indicated above each column. The …

… four booster vaccines differed significantly at day 28 for both omicron and delta (both p<0·0001),
but the ratio of omicron to delta did not differ between groups (p=0·11; appendix p 14). …

Zika virus (ZIKV) was discovered in 1947 and was thought to lead to relatively mild disease.
The recent explosive outbreak of ZIKV in South America has led to widespread concern, with …

Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …

… V2, and three in P.1, with the N501Y mutation being common to all. It is believed that these
mutations in the ACE2 receptor binding domain increase the affinity for ACE2 (Zahradnık et al.…

According to WHO, SARS-CoV-2 is estimated to have caused 265 million infections and
more than 5 million deaths over the past 2 years. Current vaccines are based on the original …